|
Curis Lifesciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
118.11 Cr.
|
P/BV
|
5.56
|
Book Value (Rs.)
|
26.28
|
|
52 Week High/Low (Rs.)
|
0/0
|
FV/ML
|
10/1000
|
P/E(X)
|
19.35
|
|
Bookclosure
|
|
EPS (Rs.)
|
7.55
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 10.29 | 97.34 | 37.51 |
| Diluted EPS (Rs.) | 10.29 | 97.34 | 37.51 |
| Cash EPS (Rs.) | 11.42 | 110.93 | 52.03 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 27.34 | 117.46 | 20.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 27.34 | 117.46 | 20.12 |
| Revenue From Operations / Share (Rs.) | 82.79 | 711.11 | 708.98 |
| PBDIT / Share (Rs.) | 16.93 | 174.03 | 84.88 |
| PBIT / Share (Rs.) | 15.80 | 160.44 | 70.36 |
| PBT / Share (Rs.) | 13.93 | 143.47 | 43.81 |
| Net Profit / Share (Rs.) | 10.29 | 97.34 | 37.51 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 20.45 | 24.47 | 11.97 |
| PBIT Margin (%) | 19.08 | 22.56 | 9.92 |
| PBT Margin (%) | 16.83 | 20.17 | 6.17 |
| Net Profit Margin (%) | 12.42 | 13.68 | 5.29 |
| Return on Networth / Equity (%) | 37.62 | 82.87 | 186.44 |
| Return on Capital Employeed (%) | 37.56 | 51.18 | 31.44 |
| Return On Assets (%) | 14.35 | 14.36 | 6.30 |
| Long Term Debt / Equity (X) | 0.46 | 1.48 | 9.72 |
| Total Debt / Equity (X) | 0.96 | 2.91 | 16.10 |
| Asset Turnover Ratio (%) | 1.29 | 1.12 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 1.78 | 1.21 | 0.93 |
| Quick Ratio (X) | 0.73 | 0.72 | 0.66 |
| Inventory Turnover Ratio (X) | 3.59 | 5.05 | 0.00 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 9.09 | 10.25 | 3.20 |
| Interest Coverage Ratio (Post Tax) (%) | 6.52 | 6.73 | 2.41 |
